Fluidigm» (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life sciences and in applied markets. Fluidigm's systems consist of instruments, software, integrated fluidic circuits (IFCs), high-performance assays for gene expression and genotyping, and primers for sample preparation for next-generation sequencing. Fluidigm technology enables customers to perform thousands of sophisticated biochemical measurements in parallel on samples smaller than the content of a single cell, with nanoliter volumes of reagents, in half the area of a credit card. The Company's integrated customer solutions are designed to significantly simplify experimental workflows, increase throughput and reduce costs while delivering excellent data quality. Based in South San Francisco, Fluidigm offers an exciting and collegial working environment with excellent compensation and benefits, including equity.